Results 181 to 190 of about 23,339 (211)
Some of the next articles are maybe not open access.

Giant cell arteritis

Current Treatment Options in Neurology, 1999
Diagnosis and management of giant cell (temporal) arteritis (GCA) should be performed by physicians who can accurately monitor the ophthalmologic, neurologic, and systemic sequelae of the disease as well as the numerous side effects of systemic corticosteroids, which are typically necessary for treatment.
, Turbin, , Kupersmith
openaire   +2 more sources

Giant cell arteritis

Current Treatment Options in Neurology, 2004
Patients with a suspected diagnosis of giant cell arteritis (GCA) should be started on high-dose corticosteroid therapy without delay. A temporal artery biopsy should be performed after initiation of therapy to confirm the diagnosis. Patients with acute visual or neurologic symptoms present a neuro-ophthalmic emergency.
Jennifer K., Hall, Laura J., Balcer
openaire   +2 more sources

Giant-Cell Arteritis

New England Journal of Medicine, 2022
Alex, Rebello, Prashant, Joshi
openaire   +4 more sources

Giant cell arteritis

Postgraduate Medicine, 2023
Giant cell arteritis (GCA, also known as temporal arteritis) is classified as a vasculitis of large and medium sized vessels and can involve the cranial vessels as well as the aorta and great vessels. It is a systemic rheumatic disease that virtually never occurs in adults younger than 50 years of age.
openaire   +2 more sources

Giant-Cell Arteritis

Annals of Internal Medicine, 1978
Excerpt Although Horton described temporal arteritis in 1932, the syndrome did not get much attention until the past decade.
openaire   +2 more sources

Giant Cell Arteritis

Neurologic Clinics, 2010
Giant cell arteritis is a systemic vasculitis with a wide clinical spectrum, and it represents a medical emergency. Visual loss is the most feared complication, and when it happens, it tends to be profound and permanent. Prompt diagnosis and treatment are imperative to minimize potentially devastating visual loss and neurologic deficits.
openaire   +2 more sources

Giant cell arteritis

Lupus, 1998
In many populations giant cell arteritis (GCA) is the most common form of vasculitis. Genetic markers, ethnic factors, and increasing age over 50 years appear to enhance susceptibility and an infection may trigger its onset. Recent investigations provide evidence that the vasculitic reaction is part of an immune response to an antigen residing in ...
openaire   +2 more sources

Giant cell arteritis

Current Opinion in Rheumatology, 1990
Giant cell arteritis is a generalized inflammatory disorder involving large and medium-sized arteries. The etiology is unknown, although an autoimmune pathogenesis seems probable. In view of the clinical similarities between patients with positive biopsy findings for polymyalgia rheumatica and those with negative biopsy findings, many authors favor the
openaire   +2 more sources

GIANT CELL ARTERITIS

The Lancet, 1980
J W, Harbison   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy